000			nab a22 7a 4500
999			_c17384 _d17384
003			PC17384
005			20230414115349.0
008			230414b xxu||||| |||| 00| 0 eng d
040			_cH12O
041			_aeng
100			_91025 _aFlores de la Cal, Ana Isabel _eBanco de Sangre de Cordón Umbilical
100			_9339 _aGómez Gómez, Gonzalo Jesús _eAparato Digestivo
100			_92286 _aMasedo González, Ángeles _eAparato Digestivo
100			_9621 _aMartínez Montiel, Pilar _eAparato Digestivo
245	0	0	_aStem cell therapy in inflammatory bowel disease: A promising therapeutic strategy?. _h[revisión]
260			_bWorld journal of stem cells, _c2015
300			_a7(2):343-51.
500			_aFormato Vancouver: Flores AI, Gómez Gómez GJ, Masedo González Á, Martínez Montiel MP. Stem cell therapy in inflammatory bowel disease: A promising therapeutic strategy?. World J Stem Cells. 2015 Mar 26;7(2):343-51.
501			_aPMID: 25815119 PMC4369491
504			_aContiene 84 referencias
520			_aInflammatory bowel diseases are inflammatory, chronic and progressive diseases of the intestinal tract for which no curative treatment is available. Research in other fields with stem cells of different sources and with immunoregulatory cells (regulatory T-lymphocytes and dendritic T-cells) opens up new expectations for their use in these diseases. The goal for stem cell-based therapy is to provide a permanent cure. To achieve this, it will be necessary to obtain a cellular product, original or genetically modified, that has a high migration capacity and homes into the intestine, has high survival after transplantation, regulates the immune reaction while not being visible to the patient's immune system, and repairs the injured tissue.
710			_9273 _aServicio de Medicina del Aparato Digestivo
710			_9625 _aInstituto de Investigación imas12
856			_uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369491/ _yAcceso libre
942			_2ddc _cREV _n0